Learn More
Medchemexpress LLC INH1 | 313553-47-8 | 99.85% | 308.40 | 100 MG

Supplier: Medchemexpress LLC HY16660100MG
INH1 specifically disrupts the Hec1/Nek2 interaction via direct Hec1 binding. It shows promising cancer inhibition activity both in vitro and in vivo. It induces abnormal mitotic processes, as well as cell apoptosis.
- Specifically disrupts the Hec1/Nek2 interaction via direct Hec1 binding.
- Exhibits promising cancer inhibition activity both in vitro and in vivo.
- Induces abnormal mitotic processes and cell apoptosis.
- Has various IC50 values against different cancer cell lines such as HeLa, K562, MDA-MB-231, and MDA-MB-468.
- Inhibits tumor outgrowth in a xenografted breast cancer model in nude mice.
- Available in solid and solution forms.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.